Colonial Trust’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.13M Sell
2,686
-46
-2% -$18.3K 0.14% 113
2026
Q2
$989K Sell
2,732
-14
-0.5% -$4.79K 0.13% 121
2026
Q1
$966K Sell
2,746
-152
-5% -$54.2K 0.13% 122
2025
Q4
$949K Sell
2,898
-860
-23% -$273K 0.13% 126
2025
Q3
$1.06M Sell
3,758
-17
-0.5% -$4.93K 0.14% 126
2025
Q2
$1.05M Buy
3,775
+473
+14% +$134K 0.15% 119
2025
Q1
$1.03M Sell
3,302
-600
-15% -$177K 0.16% 118
2024
Q4
$1.02M Sell
3,902
-337
-8% -$100K 0.15% 118
2024
Q3
$1.37M Buy
4,239
+694
+20% +$227K 0.21% 99
2024
Q2
$1.11M Buy
3,545
+136
+4% +$40K 0.2% 96
2024
Q1
$969K Buy
3,409
+109
+3% +$31.9K 0.18% 102
2023
Q4
$950K Buy
3,300
+990
+43% +$270K 0.2% 103
2023
Q3
$621K Buy
2,310
+8
+0.3% +$2K 0.15% 117
2023
Q2
$511K Buy
2,302
+1,280
+125% +$297K 0.12% 129
2023
Q1
$247K Buy
1,022
+61
+6% +$15K 0.06% 206
2022
Q4
$252K Sell
961
-108
-10% -$29K 0.07% 184
2022
Q3
$241K Hold
1,069
– – 0.08% 180

Other funds holding AMGN

Colonial Trust's AMGN Position: Q3 2026 in Review

Colonial Trust reduced its Amgen (AMGN) stake by 1.7% in Q3 2026, selling an estimated $18.3K and leaving 2,686 shares worth $1.13M. The position accounts for 0.14% of the portfolio, ranked #113.

Colonial Trust first reported a position in AMGN in Q3 2022 and has held it in 17 quarters since. The position peaked at $1.37M in Q3 2024. 3,275 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Colonial Trust held 2,686 shares of Amgen worth $1.13M as of Q3 2026.
  • Colonial Trust sold 46 Amgen shares in Q3 2026, an estimated $18.3K.
  • Amgen made up 0.14% of Colonial Trust's portfolio in Q3 2026, its #113 holding.
  • Colonial Trust first reported a position in Amgen in Q3 2022 and has held it in 17 quarters since.
  • Colonial Trust's Amgen position peaked at $1.37M in Q3 2024.
  • 3,275 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Colonial Trust's 13F filing for Q3 2026, filed 10 Nov 2026.